Supraglottic Airway for Resuscitation Trial (NCT07150923) | Clinical Trial Compass
RecruitingNot Applicable
Supraglottic Airway for Resuscitation Trial
United States36,503 participantsStarted 2026-01-01
Plain-language summary
This is a hybrid type 3 effectiveness-implementation parallel cluster randomized superiority trial designed to compare two strategies to promote early supraglottic airway (SA) rescue during neonatal resuscitation, with a focus on implementation outcomes.
Who can participate
Age range0 Days
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Population 1: Hospital Staff
Population 1a: Clinical providers and administrators who complete study questionnaires
Clinical provider 1a inclusion criteria:
* Employed full-time by the hospital, affiliated practice, or affiliated university in a role that involves newborn resuscitation
* Fluent in English
Administrator 1a inclusion criteria
* Oversee the care of newborns on a local level (e.g. nurse manager) or a hospital level (e.g. Chief Quality and Safety Officer)
* Fluent in English
Clinical provider and administrator exclusion 1a criteria: No exclusion criteria
Population 1b: Clinical providers who participate in qualitative interviews
Clinical provider 1b inclusion criteria:
* Employed full-time by the hospital, affiliated practice, or affiliated university in a role that involves newborn resuscitation
* Fluent in English
Clinical provider 1b exclusion criteria: No exclusion criteria
Population 2: Patients who receive neonatal resuscitation at birth
Inclusion Criteria:
* Inborn (not transferred to the hospital after birth)
* ≥34 weeks' gestation at birth, based on best obstetrical estimate
* Received PPV during neonatal resuscitation (as per provider's clinical assessment)
Exclusion Criteria:
* Congenital diaphragmatic hernia
* Airway anomalies